Sun Zhiheng, He Wanyu, Meng Huiwen, Li Peizhi, Qu Junxing
College of Life Science, Institute of Biomedical Science, Henan Normal University, Xinxiang, Henan, China.
State Key Laboratory of Cell Differentiation and Regulation, Xinxiang, Henan, China.
FASEB J. 2024 Dec 15;38(23):e70232. doi: 10.1096/fj.202401849RR.
Pulmonary fibrosis (PF) is a progressive and irreversible lung disease that leads to diminished lung function, respiratory failure, and ultimately death and typically has a poor prognosis, with an average survival time of 2 to 5 years. Related articles suggested that endoplasmic reticulum (ER) stress played a critical role in the occurrence and progression of PF. The ER is responsible for maintaining protein homeostasis. However, factors such as aging, hypoxia, oxidative stress, or inflammation can disrupt this balance, promoting the accumulation of misfolded proteins in the ER and triggering ER stress. To cope with this situation, cells activate the unfolded protein response (UPR). Since acute lung injury (ALI) is one of the key onset events of PF, in this review, we will discuss the role of ER stress in ALI and PF by activating multiple signaling pathways and molecular mechanisms that affect the function and behavior of different cell types, with a focus on epithelial cells, fibroblasts, and macrophages. Linking ER stress to these cell types may broaden our understanding of the mechanisms underlying lung fibrosis and help us target these cells through these mechanisms. The relationship between ER stress and PF is still evolving, and future research will explore new strategies to regulate UPR pathways, providing novel therapeutic targets.
肺纤维化(PF)是一种进行性且不可逆的肺部疾病,会导致肺功能下降、呼吸衰竭,并最终导致死亡,其预后通常较差,平均生存时间为2至5年。相关文章表明,内质网(ER)应激在PF的发生和发展中起关键作用。内质网负责维持蛋白质稳态。然而,衰老、缺氧、氧化应激或炎症等因素会破坏这种平衡,促使错误折叠的蛋白质在内质网中积累并引发内质网应激。为应对这种情况,细胞会激活未折叠蛋白反应(UPR)。由于急性肺损伤(ALI)是PF的关键起始事件之一,在本综述中,我们将通过激活多种信号通路和分子机制来讨论内质网应激在ALI和PF中的作用,这些机制会影响不同细胞类型的功能和行为,重点关注上皮细胞、成纤维细胞和巨噬细胞。将内质网应激与这些细胞类型联系起来,可能会拓宽我们对肺纤维化潜在机制的理解,并帮助我们通过这些机制靶向这些细胞。内质网应激与PF之间的关系仍在不断发展,未来的研究将探索调节UPR通路的新策略,提供新的治疗靶点。